References
- Winchester R., Dwyer E., Rose S. The genetic basis of rheumatoid arthritis. The shared epitope hypothesis. Rheum Dis Clin North Am 1992; 18: 761–83
- Nelson J. L., Mickelson E., Masewicz S., Barrington R., Dugowson C., Koepsell T., et al. Dw14(DRB1*0404) is a Dw4‐dependent risk factor for rheumatoid arthritis. Rethinking the ‘shared epitope’ hypothesis. Tissue Antigens 1991; 38: 141–51
- Penzotti J. E., Doherry D., Lybrand T. P., Nepom G. T. A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis. J Autoimmun 1996; 9: 287–93
- Schellekens G. A., De Jong B. A., Van Den Hoogen F. H. J., Van de Putte L. B. A., Van Venroooij W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis specific auto‐antibodies. J Clin Invest 1998; 101: 273–81
- Nikolaisen C., Rekvig O. P., Nossent H. C. Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis. Scand J Rheumatol 2007; 36: 97–100
- Girbal Neuhauser E., Durieux J. J., Arnaud M., Dalbon P., Sebbag M., Vincent C., et al. The epitopes targeted by the rheumatoid arthritis associated antifilaggrin auto‐antibodies are posttranslationally generated on various sites of filaggrin by deimination of arginine residues. J Immunol 1999; 162: 585–94
- Schellekens G. A., Visser H., de Jong B. A., van den Hoogen F. H., Hazes J. M., Breedveld F. C., et al. The diagnostic properties of rheumatoid arthritis recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155–63
- Gu Y. L., Lv L., Chen Y. M., Xu M. L. The research of anti‐cyclic citrullinated peptide antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis. Chinese J Rheum 2005; 9: 41–4
- Kwok J. S., Hui K. H., Lee T. L., Wong W., Lau Y. L., Wong R. W., et al. Anti‐cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Scand J Rheumatol 2005; 34: 359–66
- van Gaalen F. A., van Aken J., Huizinga T. W. J., Schreuder G. M. Th., Breedveld F. C., Zanelli E., et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004; 50: 2113–21
- Senkpiehl I., Marget M., Wedler M., Jenisch S., Georgi J., Kabelitz D., et al. HLA‐DRB1 and anti‐cyclic citrullinated peptide antibody production in rheumatoid arthritis. J Int Arch Allergy Immunol 2005; 137: 315–18
- Irigoyen P., Lee A. T., Wener M. H., Li W., Kern M., Batliwalla F., et al. Regulation of anti‐cyclic citrullinated peptide antibodies in rheumatoid arthritis. Arthritis Rheum 2005; 52: 3813–18
- Schumacher H. R., Gall E. P. Rheumatoid arthritis: an illustrated guide to pathology, diagnosis, and management. JB Lippincott, Philadelphia 1988
- Zhu N. Sh., Wang Y. X., Wang F. Q. The association of HLA‐DRB1 alleles with rheumatoid arthritis in Chinese. Chinese J Med 1994; 428–30
- Pan Zh. L., Zhang Y. Ch. Meta analysis of HLA‐DRB1 shared epitope carriership in Chinese patients with RA. Chinese J Rheum 2004; 8: 662–8
- Suzuki A., Yamada R., Chang X., Tokuhiro S., Sawada T., Suzuki M., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003; 34: 394–402